Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Cipla Community
NSEI:CIPLA Community
1
Narratives
written by author
0
Comments
on narratives written by author
35
Fair Values set
on narratives written by author
Community Investing Ideas
Cipla
Popular
Undervalued
Overvalued
Cipla
AN
AnalystConsensusTarget
Consensus Narrative from 36 Analysts
Emerging Markets And Chronic Therapies Will Open New Horizons
Key Takeaways Expansion in chronic therapies and complex generics, combined with digital and e-pharmacy investments, drives sustainable revenue and margin growth across key global markets. Manufacturing self-reliance and compliance strengths position Cipla to capitalize on supply chain shifts and localization trends, supporting long-term profitability and export growth.
View narrative
₹1.68k
FV
5.0% undervalued
intrinsic discount
8.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
CIPLA
CIPLA
Cipla
Your Fair Value
₹
Current Price
₹1.59k
23.7% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
405b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹405.0b
Earnings ₹79.5b
Advanced
Set Fair Value